Overview

Comparison of 30 Units of TI (Technosphere® Insulin) Prepared With Insulin From Two Different Suppliers

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
A Phase 1, open-label randomized crossover trial in Healthy Volunteers to evaluate the PK/PD of TI (Technosphere® Insulin) prepared with insulin from two different suppliers.
Phase:
Phase 1
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Insulin
Insulin, Globin Zinc